Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 19:20
Anika Therapeutics Debt to Equity Ratio : 0.1839 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1839 |
| March 31, 2026 | 0.1922 |
| December 31, 2025 | 0.183 |
| September 30, 2025 | 0.1669 |
| June 30, 2025 | 0.1692 |
| March 31, 2025 | 0.1714 |
| December 31, 2024 | 0.1684 |
| September 30, 2024 | 0.1531 |
| June 30, 2024 | 0.1335 |
| March 31, 2024 | 0.1365 |
| December 31, 2023 | 0.1307 |
| September 30, 2023 | 0.1083 |
| June 30, 2023 | 0.109 |
| March 31, 2023 | 0.1095 |
| December 31, 2022 | 0.1082 |
| September 30, 2022 | 0.1092 |
| June 30, 2022 | 0.1105 |
| March 31, 2022 | 0.0716 |
| December 31, 2021 | 0.073 |
| September 30, 2021 | 0.073 |
| June 30, 2021 | 0.0753 |
| March 31, 2021 | 0.0802 |
| December 31, 2020 | 0.0825 |
| September 30, 2020 | 0.1679 |
| June 30, 2020 | 0.2533 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0798 |
| December 31, 2019 | 0.0781 |
| September 30, 2019 | 0.0806 |
| June 30, 2019 | 0.092 |
| March 31, 2019 | 0.0866 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics, Inc. | 0.0122 |
| MiMedx Group, Inc. | 0.0797 |
| ABVC BioPharma, Inc. | 0.2807 |
| Enovis Corp. | 0.9269 |
| Edwards Lifesciences Corp. | 0.0663 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 183.47M |
| Total Liabilities (Quarterly) | 46.19M |
| Shareholders Equity (Quarterly) | 137.28M |
| Current Ratio | 4.479 |
| Net Debt Paydown Yield | 0.02% |